Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
(+)-naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats.
Are there evidence-based dietary interventions for multiple sclerosis?
Novel MRI and PET markers of neuroinflammation in multiple sclerosis.
Zinc sulphate: A reasonable choice for depression management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial.
Combining Self-help and Professional Help to Minimize Barriers to Physical Activity in Persons With Multiple Sclerosis: A Trial of the "Blue Prescription" Approach in New Zealand.
Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
New therapeutic approach by G2013 in experimental model of multiple sclerosis.
Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis.
Integrating the ICF with positive psychology: Factors predicting role participation for mothers with multiple sclerosis.
Morphometric and quantitative immunohistochemical analysis of disease-related changes in the upper (suburothelial) lamina propria of the human bladder dome.
Multiple Sclerosis International Federation: Stimulating international cooperation in research.
Squinting Through Layers of Fog: Assessing the Cost Effectiveness of Treatments for Multiple Sclerosis.
Examination of Cognitive Fatigue in Multiple Sclerosis using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging.
Translation and Cultural Adaptation of the Multidimensional Scale of Perceived Social Support for Greece.
Multiple sclerosis: Cognitive training provides lasting benefits for patients with multiple sclerosis.
The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination.
Two-Photon Fluorescent Imaging of Myelination in the Spinal Cord.
Multiple sclerosis: Activation of cortical microglia linked to level of disability in patients with multiple sclerosis.
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season.
Analysis of retinal nerve fibre layer, visual evoked potentials and relative afferent pupillary defect in multiple sclerosis patients.
Glial cells suppress postencephalitic CD8(+) T lymphocytes through PD-L1.
Multiple sclerosis drug fingolimod receives new safety warnings related to cardiovascular risk.
Abstracts of the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis. October 10-13, 2012. Lyon, France.
IL-17-Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions.
Accelerometry as a measure of walking behavior in multiple sclerosis.
Pages
« first
‹ previous
…
381
382
383
384
385
386
387
388
389
…
next ›
last »